Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5546/aap.2021.S198 http://scihub22266oqcxt.onion/10.5546/aap.2021.S198 34309328!ä!34309328 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Arch+Argent+Pediatr 2021 ; 119 (4): S198-S211 Nephropedia Template TP {{tp|p=34309328|t=2021. Consenso sobre el tratamiento del sindrome inflamatorio multisistemico asociado a COVID-19 |pdf=|usr=}}{{34309328}} gab.com Text Consenso sobre el tratamiento del sindrome inflamatorio multisistemico asociado a COVID-19 JO: Arch Argent Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=34309328 #FOAvip The pandemic caused by the SARS-CoV-2 virus declared by the WHO in March 11th 2020, affects a small number of pediatric patients, who mostly present mild respiratory compromise and favorable evolution. However began to be observed in previously healthy children, an increase in cases defined as "Multisystemic Inflammatory Syndrome" (MIS-C) or "Kawasaki-like" post-COVID 19 (KLC) that evolve to shock and require hospitalization in the Pediatric Intensive Care Unit. MIS-C and KL-C are characterized by fever; signs of inflammation, gastrointestinal symptoms, and cardiovascular dysfunction, associated with sever forms of presentation with higher incidence of hypotension and/or shock. In the laboratory, markers of inflammation, hypercoagulability and myocardial damage are observed. Firstline drug treatment consists of intravenous immunoglobulin plus oral acetylsalicylic acid. A multidisciplinary approach is recommended for an accurate diagnosis and an early and effective treatment, in order to reduce morbidity and mortality. Twit Text FOAVip Consenso sobre el tratamiento del sindrome inflamatorio multisistemico asociado a COVID-19 ????Arch Argent Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=34309328 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34309328 #FOAvip English Wikipedia <ref>{{Cite pmid|34309328}}</ref> Consenso sobre el tratamiento del sindrome inflamatorio multisistemico asociado a COVID-19 #MMPMID34309328 Ensinck G; Gregorio G; Flores RM; Crowe CI; Clerico Mosina P; Curi C; Jorro Baron F; Kohn Loncarica G; Grinenco S; Rios C; Gonzalez C; Zaslavsky V; Lillo L; Vainstein E; Urrutia L Arch Argent Pediatr 2021[Aug]; 119 (4): S198-S211 PMID34309328show ga The pandemic caused by the SARS-CoV-2 virus declared by the WHO in March 11th 2020, affects a small number of pediatric patients, who mostly present mild respiratory compromise and favorable evolution. However began to be observed in previously healthy children, an increase in cases defined as "Multisystemic Inflammatory Syndrome" (MIS-C) or "Kawasaki-like" post-COVID 19 (KLC) that evolve to shock and require hospitalization in the Pediatric Intensive Care Unit. MIS-C and KL-C are characterized by fever; signs of inflammation, gastrointestinal symptoms, and cardiovascular dysfunction, associated with sever forms of presentation with higher incidence of hypotension and/or shock. In the laboratory, markers of inflammation, hypercoagulability and myocardial damage are observed. Firstline drug treatment consists of intravenous immunoglobulin plus oral acetylsalicylic acid. A multidisciplinary approach is recommended for an accurate diagnosis and an early and effective treatment, in order to reduce morbidity and mortality. |Adolescent[MESH] |Anti-Inflammatory Agents/therapeutic use[MESH] |COVID-19 Testing[MESH] |COVID-19/*diagnosis/physiopathology/*therapy[MESH] |Child[MESH] |Child, Preschool[MESH] |Combined Modality Therapy[MESH] |Critical Care/methods[MESH] |Diagnosis, Differential[MESH] |Early Diagnosis[MESH] |Humans[MESH] |Immunoglobulins, Intravenous/therapeutic use[MESH] |Immunologic Factors/therapeutic use[MESH] |Infant[MESH] |Infant, Newborn[MESH] |Respiratory Therapy/methods[MESH]Consenso sobre el tratamiento del sindrome inflamatorio multisistemico(epmc).pdf DeepDyve Pubget Overpricing